Population Health Essentials Oct 2021
IMPORTANT BROWSER INFORMATION |
---|
This site will not work on Internet Explorer 8. Please use: |
Population Health Essentials offers a 3-day comprehensive overview of population health and outlines the fundamentals necessary to improve outcomes and reduce costs.
Through case studies and real-life workforce applications, participants will review and analyze key areas of population health.
Registration
To register, visit the College of Population Health.
Successful Completion
To successfully complete this activity, the required evaluation must be completed by the following dates. Thereafter, the evaluation will no longer be available and credits will not be issued.
Physicians/Nurses/Other Healthcare Professionals: The required evaluation must be completed by Thursday, December 2, 2021.
Pharmacists: The required evaluation must be completed by Wednesday, November 17, 2021. The shorter completion date is to allow for time to upload into CPD Monitor.
Target Audience
Clinicians, practitioners, administrators and executives from healthcare related industries, hospital systems, pharmaceutical and medical device companies, employers, insurers and consultants.
Learning Objectives
Following this educational activity, learners will be able to:
- Examine the role of key stakeholders and their complex interrelationships on population health outcomes in the US healthcare system.
- Describe the population health paradigm.
- Identify models and strategies for population health management and creating a culture of wellness.
- Examine the economic concept of risk as it applies to healthcare.
- Apply risk management theory to population health management.
- Discuss the impact that social determinants of health have on health outcomes .
- Discuss interventions that reduce the impacts of SDOH, improve health outcomes and decrease health care costs.
- Explain the necessity for data management and analytics for population health, in care delivery, care coordination, patient engagement and organizational
decision making. - Discuss the role of quality improvement in the context of population health management.
- Define models of care coordination and care management that proactively manage patient care across the continuum.
Commercial/In-Kind Support
This educational activity received no commercial or in-kind support.
Online Meeting
This educational activity will be held via zoom. Information for accessing the activity will be sent via email.
Conflict of interest
Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.
All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.
Exception: According to the Standards, it is not required to identify, mitigate, or disclose relevant financial relationships for any of the following activities:
- Accredited education that is non-clinical, such as leadership or communication skills training.
- Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
- Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted, such as learning from teaching, remediation, or a personal development plan.
Planning Committee
Mitchell Kaminski, MD, MBA-Activity Director
Vittorio Maio, PharmD
Ellen Guarnieri, RN, MHSA, CPHQ, FACHE
Melissa Harowitz
Faculty
Mitchell Kaminski, MD, MBA
Mary R Cooper, MD, JD
Harm Scherpbier, MD, MS
Mary Jane Osmick, MD
David Sarcone, PhD
Shiva Chandrasekaren, MD
Off‐label/Investigational Use
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians: This educational activity is designated for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 24.25 nursing contact hours.
Pharmacists: This knowledge-based continuing education activity is designated for 24.25 contact hours of continuing education credit. JA4008236-0000-21-032-L04-P
Credits will be uploaded to CPE Monitor within 60 days following the completion of this activity.
This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
Other Healthcare Professionals: This educational activity is designated for 24.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Credit count includes .25 credit for completion of the required online evaluation.
Other Credit Type
PA Patient Safety and Risk Credit: This educational activity qualifies for 3.75 PA Patient Safety and Risk credit.
Qualifying Sessions:
Day 1:Quality and Safety 1.75 credit
Day 2: Population Health Management 2.0 credit
Available Credit
- 24.25 ACPE
- 24.25 AMA PRA Category 1 Credit™
- 24.25 Attendance
- 24.25 CNE
- 3.75 Patient Safety